BioNTech SE (BNTX) Total Liabilities (2018 - 2026)

BioNTech SE has reported Total Liabilities for 8 years, with the latest figure at $3.2 billion in Q4 2025.

• Quarterly Total Liabilities fell 3.44% year-over-year to $3.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 billion (down 3.44% YoY) and the FY2025 annual result came in at $3.1 billion, down 6.28% from the prior year.
• Total Liabilities slipped to $3.2 billion in Q4 2025 per BNTX's latest filing, from $3.3 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $6.5 billion in Q3 2021 and troughed at $7.0 million in Q4 2021.
• A 5-year average of $3.3 billion and a median of $3.3 billion in 2022 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2021 and 2022: Total Liabilities plunged 99.38% in 2021, then jumped 47029.01% in 2022.
• Over 5 years, Total Liabilities stood at $7.0 million in 2021, then surged by 47029.01% to $3.3 billion in 2022, then fell by 9.69% to $3.0 billion in 2023, then gained by 12.21% to $3.3 billion in 2024, then slipped by 3.44% to $3.2 billion in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $3.2 billion, $3.3 billion, and $3.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.